Design Therapeutics (DSGN) added ~15% on Thursday after RBC Capital Markets upgraded the stock to Outperform from Sector Perform, citing a catalyst-rich period for the small molecule drug developer in ...
RBC Capital lowered the firm’s price target on Jack in the Box (JACK) to $16 from $22 and keeps an Outperform rating on the shares. The company’s ...
West Fraser Timber Co. Ltd. (NYSE:WFG) ranks among the best sustainability stocks to invest in. On October 24, RBC Capital ...
RBC supports the various ways that people learn, including coaching and mentoring, online learning and the interpersonal ...
CRISPR Therapeutics AG (NASDAQ: CRSP) is one of the best gene-editing stocks to buy according to hedge funds. On November 11, ...
Mr. Kedwell is a seasoned investment professional with nearly 30 years of experience at RBC. In his current role as Managing Director, Senior Portfolio Manager, and Global Head of Equities, Mr.
Investing.com -- RBC Capital Markets has initiated coverage on the British engineering company Rolls-Royce Holdings Plc (LON: ...
Traders should take cover from a protracted selloff in the dollar that could mirror the boom-and-bust cycle of the Internet bubble once the drivers that are supporting the currency turn into headwinds ...